Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

Dr. Mehmet Oz on Monday declined to offer any insights into President Donald Trump’s plan to replace the Affordable Care Act ...

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in ...

Eli Lilly and Novo Nordisk agree to expand access and cut prices for Zepbound and Wegovy • Medicare to begin covering obesity ...

The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...

The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.

Trump warned at the press conference that if an agreement is not reached with the Democrats, programs like Social Security, Medicaid, and Medicare will be in danger. There are currently no changes to ...

But the Tax Foundation calculated that a $2,000 tariff dividend for each person earning under $100,000 would cover 150 ...